CA2154854C - Lymphocytes immortalises pour l'obtention de proteines exemptes de virus - Google Patents

Lymphocytes immortalises pour l'obtention de proteines exemptes de virus Download PDF

Info

Publication number
CA2154854C
CA2154854C CA002154854A CA2154854A CA2154854C CA 2154854 C CA2154854 C CA 2154854C CA 002154854 A CA002154854 A CA 002154854A CA 2154854 A CA2154854 A CA 2154854A CA 2154854 C CA2154854 C CA 2154854C
Authority
CA
Canada
Prior art keywords
ebv
recombinant plasmid
immortalized
human
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002154854A
Other languages
English (en)
Other versions
CA2154854A1 (fr
Inventor
William M. Sugden
Wolfgang F. Hammerschmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4427117A external-priority patent/DE4427117C1/de
Priority claimed from US08/504,494 external-priority patent/US5716845A/en
Application filed by Individual filed Critical Individual
Publication of CA2154854A1 publication Critical patent/CA2154854A1/fr
Application granted granted Critical
Publication of CA2154854C publication Critical patent/CA2154854C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
CA002154854A 1994-07-30 1995-07-27 Lymphocytes immortalises pour l'obtention de proteines exemptes de virus Expired - Fee Related CA2154854C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4427117A DE4427117C1 (de) 1994-07-30 1994-07-30 Plasmid und damit transfizierte Zellen
DEP4427117.4 1994-07-30
US08/504,494 US5716845A (en) 1995-07-20 1995-07-20 Immortalized lymphocytes for production of viral-free proteins
US08/504,494 1995-07-20

Publications (2)

Publication Number Publication Date
CA2154854A1 CA2154854A1 (fr) 1996-01-31
CA2154854C true CA2154854C (fr) 2006-03-14

Family

ID=25938843

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002154854A Expired - Fee Related CA2154854C (fr) 1994-07-30 1995-07-27 Lymphocytes immortalises pour l'obtention de proteines exemptes de virus

Country Status (2)

Country Link
JP (1) JPH08168382A (fr)
CA (1) CA2154854C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3085975A1 (fr) * 2017-12-20 2019-06-27 Glaxosmithkline Biologicals Sa Constructions d'antigene du virus epstein-barr

Also Published As

Publication number Publication date
JPH08168382A (ja) 1996-07-02
CA2154854A1 (fr) 1996-01-31

Similar Documents

Publication Publication Date Title
Redwood et al. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception
Kempkes et al. Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA
Lee et al. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro
Chang et al. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis
Lee et al. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus
US7163685B2 (en) Human cytomegalovirus antigens expressed in MVA and methods of use
Pavlova et al. An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA
Delecluse et al. The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy
Wang et al. A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM
Yetming et al. The BHLF1 locus of Epstein-Barr virus contributes to viral latency and B-cell immortalization
Rooney et al. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes
Hahn et al. Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique
US5716845A (en) Immortalized lymphocytes for production of viral-free proteins
Schuessler et al. Charge cluster-to-alanine scanning of UL128 for fine tuning of the endothelial cell tropism of human cytomegalovirus
Donofrio et al. Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model
ZA200501193B (en) Non-human herpesviruses as vectors.
CA2154854C (fr) Lymphocytes immortalises pour l'obtention de proteines exemptes de virus
EP4014991A1 (fr) Parapoxvirus modifié à immunogénicité accrue
Ryan et al. Isolation of a simian virus 40 T-antigen-positive, transformation-resistant cell line by indirect selection
US6291246B1 (en) DNA virus vectors and methods for their preparation
US6436693B1 (en) Method for helper virus-free packaging of a gene vector DNA
MXPA95003231A (en) Immortalized lymphocytes for the production of vi-free propelles
Klaman et al. Is there a unique episome in EBV transformed B cells?
Ikuta et al. Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus
Davidson Establishment of Biochemically Transformed Cell Lines which Express Herpes Simplex Virus Type 1 Genes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed